Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on September 19, 2025

Introducing Nursing Science Consulting Services and Clinical Inquiry Training From Nursing Science Partners
EIN Presswire Integrates ChatGPT Into Distribution Reports to Track AI Impact on Press Releases
World-Renowned Sports Medicine Expert Dr. Yoav Nagar Expands Elite Athlete Treatment Program
Press Release - Your Life in Time, Signs, and Alchemy - Dr. Ruth Gannon Cook
Sioux Falls School District Opens First SmartLab at New Marcella LeBeau Elementary
NeuroAnimation Debuts First Wellness Therapy Shown to Grow the Brain, Reports Life-Changing Results for Clients
Kings View and OpiAID Sign Landmark Licensing Agreement to Elevate Addiction Recovery Across California
Unveiling the Therapeutic Potential of Abaloparatide in Treating Periodontal Dehiscence
CEA Industries Board Authorizes $250 Million Stock Buyback Program
KFSHRC akan Berpartisipasi dalam KTT C3 Davos of Healthcare™ Jepang
キング・ファイサル・スペシャリスト病院・研究センター (KFSHRC)、C3 ダボス・オブ・ヘルスケア™ 日本サミット (C3 Davos of Healthcare™ Japan Summit) に参加
킹파이살 전문병원 겸 연구센터 (KFSHRC), C3 다보스 어브 헬스케어™ 일본 정상회의 참가 예정
KFSHRC akan Menyertai Sidang Kemuncak C3 Davos of Healthcare™ di Jepun
KFSHRC 将参加 C3 Davos of Healthcare™日本峰会
KFSHRC เข้าร่วมการประชุมสุดยอดญี่ปุ่น C3 Davos of Healthcare™
KFSHRC 將參加 C3 Davos of Healthcare™ 日本高峰會
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction
RedCloud to Present AI-Native Vision to Digitize and Transform Global Trade
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions